Browse > Article
http://dx.doi.org/10.14475/kjhpc.2020.23.1.11

Association between D-Dimer Levels and the Prognosis of Terminal Cancer Patients in the Last Hours of Life  

Lee, Hwan Hee (Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine)
Hwang, In Cheol (Department of Family Medicine, Gil Medical Center, Gachon University College of Medicine)
Shin, Jinyoung (Department of Family Medicine, Konkuk University Medical Center, Konkuk University School of Medicine)
Publication Information
Journal of Hospice and Palliative Care / v.23, no.1, 2020 , pp. 11-16 More about this Journal
Abstract
Purpose: D-dimer levels are known to be associated with poor outcomes in patients with various cancers, but their significance at the end of life remains unclear. This study investigated D-dimer levels as a prognostic indicator for terminal cancer patients in the last hours of life. Methods: The retrospective study was conducted at a palliative care unit of a tertiary cancer center, using a database to analyze the records of patients treated from January 1, 2010 to December 31, 2018. In total, 67 terminal cancer patients with available data on D-dimer levels were included. Patients' demographic data, clinical information, and laboratory values, including D-dimer levels, were collected. Survival was analyzed using the Kaplan-Meier method and the log-rank test. A Cox proportional-hazards model was used to identify prognostic factors of poor survival. Results: The most common site of cancer was the lung (32.8%) and the median survival time was 5 days. Most laboratory results, particularly D-dimer levels, deviated from the normal range. Patients with high D-dimer levels had a significantly shorter survival time than those with low D-dimer levels (4 days vs. 7 days; P=0.012). In the Cox regression analysis, only a high D-dimer level was identified as a predictor of a poor prognosis (hazard ratio, 1.83; 95% confidence interval, 1.09~3.07). Conclusion: Our results suggest that at the very end of life, D-dimer levels may serve as a prognostic factor for survival in cancer patients.
Keywords
Fibrin fibrinogen degradation products; Hospice care; Neoplasms; Prognosis; Survival;
Citations & Related Records
연도 인용수 순위
  • Reference
1 Adam SS, Key NS, Greenberg CS. D-dimer antigen: current concepts and future prospects. Blood 2009;113:2878-87.   DOI
2 Verhovsek M, Douketis JD, Yi Q, Shrivastava S, Tait RC, Baglin T, et al. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism. Ann Intern Med 2008;149:481-90, W94.   DOI
3 Yamamoto M, Yoshinaga K, Matsuyama A, Iwasa T, Osoegawa A, Tsujita E, et al. Plasma D-dimer level as a mortality predictor in patients with advanced or recurrent colorectal cancer. Oncology 2012;83:10-5.   DOI
4 Motavaf E, Sunesen KG, Stender MT, Thorlacius-Ussing O. Prognostic value of preoperative D-dimer and carcinoembryonic antigen levels in patients undergoing intended curative resection for colorectal cancer: a prospective cohort study. Int J Colorectal Dis 2014;29:1427-32.   DOI
5 Zhou YX, Yang ZM, Feng J, Shan YJ, Wang WL, Mei YQ. High plasma D-dimer level is associated with decreased survival in patients with lung cancer: a meta-analysis. Tumour Biol 2013;34:3701-4.   DOI
6 Khoury JD, Adcock DM, Chan F, Symanowski JT, Tiefenbacher S, Goodman O, et al. Increases in quantitative D-dimer levels correlate with progressive disease better than circulating tumor cell counts in patients with refractory prostate cancer. Am J Clin Pathol 2010;134:964-9.   DOI
7 Go SI, Lee MJ, Lee WS, Choi HJ, Lee US, Kim RB, et al. D-Dimer Can Serve as a Prognostic and Predictive Biomarker for Metastatic Gastric Cancer Treated by Chemotherapy. Medicine (Baltimore) 2015;94:e951.   DOI
8 Falanga A, Panova-Noeva M, Russo L. Procoagulant mechanisms in tumour cells. Best Pract Res Clin Haematol 2009;22:49-60.   DOI
9 Lee IC, Kim CK, Suh SY, Kim YS, Cho KH, Kang HC, et al. Validation of Scoring System for Survival Prediction in Terminal Cancer Patients in Korea. J Korean Acad Fam Med 2007;28:682-9.
10 Suh SY. Survival prediction of terminally ill cancer patients. Korean J Hosp Palliat Care 2007;10:171-7.
11 Repetto L, Fratino L, Audisio RA, Venturino A, Gianni W, Vercelli M, et al. Comprehensive geriatric assessment adds information to Eastern Cooperative Oncology Group performance status in elderly cancer patients: an Italian Group for Geriatric Oncology Study. J Clin Oncol 2002;20:494-502.   DOI
12 Heit JA, Silverstein MD, Mohr DN, Petterson TM, O'Fallon WM, Melton LJ, 3rd. Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med 2000;160:809-15.   DOI
13 den Daas N. Estimating length of survival in end-stage cancer: a review of the literature. J Pain Symptom Manage 1995;10:548-55.   DOI
14 Park HJ, Choi YS, Kim SM, Kim JE, Kim EH, Kim EY, et al. Validation of the objective prognostic score for terminal cancer patients in a tertiary hospital. Korean J Clin Geri 2016;17:59-67.   DOI
15 Rao BB, Kalayarasan R, Kate V, Ananthakrishnan N. Venous thromboembolism in cancer patients undergoing major abdominal surgery: Prevention and management. Int Sch Res Notices 2012;2012:1-22.   DOI
16 Tichelaar YI, Kluin-Nelemans HJ, Meijer K. Infections and inflammatory diseases as risk factors for venous thrombosis. A systematic review. Thromb Haemost 2012;107:827-37.   DOI
17 Bounameaux H, de Moerloose P, Perrier A, Reber G. Plasma measurement of D-dimer as diagnostic aid in suspected venous thromboembolism: an overview. Thromb Haemost 1994;71:1-6.   DOI